BridgeMD
Compares treatment options for Plantar Fasciitis
Official title Botulinum Toxin A Versus Steroids for the Treatment of Chronic Plantar Fasciitis
ClinicalTrials.gov ID: NCT02196155
What this study is testing
What is Botulinum toxin A?
Botulinum toxin A is an investigational medicine, given as an injectable medicine, being studied as a potential treatment for plantar fasciitis.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Plantar fasciitis is the classic and most common type of heel pain. Considering the costs for health care and the temporary disability not only for work, plantar fasciitis results in a substantial (and at least partially unnecessary) burden for the Swiss health care system and national economics.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 60
You may be able to join if
- Clinical symptoms of a plantar fasciitis
- Plantar fasciitis in MRI
- Exclusion of differential diagnoses
- Symptoms more than 3 months
- Absolution of 3 months unsuccessful treatment
You likely can't join if
- Active differential diagnoses
- Contraindications: pregnancy and breastfeeding, infection at injection sites, allergy against BTX-A
- Previous injections or surgery for plantar fasciitis
- Neurological diseases affecting the peripheral nervous system
See the full eligibility criteria
- Clinical symptoms of a plantar fasciitis
- Plantar fasciitis in MRI
- Exclusion of differential diagnoses
- Symptoms more than 3 months
- Absolution of 3 months unsuccessful treatment
- Written informed consent
- Active differential diagnoses
- Contraindications: pregnancy and breastfeeding, infection at injection sites, allergy against BTX-A
- Previous injections or surgery for plantar fasciitis
- Neurological diseases affecting the peripheral nervous system
The study team makes the final eligibility decision.
Where it's taking place
- Bern, Switzerland
- Lucerne, Switzerland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 60 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bern, Switzerland; Lucerne, Switzerland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.